Travere Therapeutics names Bradley Campbell CEO as Eric Dube exitsSep 21PeopleTravere Therapeutics, Inc.
Amicus reports FY2025 results as BioMarin merger deal proceedsJul 13PeopleBiomarin Pharmaceutical Inc
Sign inSign in